Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated VaccineBenjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Nature Communications|July 30, 2021
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionCarolyn A Cohen, Athena P Y Li, Asmaa Hachim, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled TrialBenjamin J Cowling, Sook-San Wong, Jefferson J S Santos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2024
Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled TrialBenjamin J Cowling, Sook-San Wong, Jefferson J S Santos, et al.
Respirology (Carlton, Vic.)|November 25, 2021
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong KongChris Ka Pun Mok, Carolyn A Cohen, Samuel M S Cheng, et al.
Vaccine|September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccineEunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Virus Evolution|July 16, 2025
Surveillance of coronaviruses in wild aquatic birds in Hong Kong: expanded genetic diversity and discovery of novel subgenus in the <i>Deltacoronavirus</i>Daisy Y M Ng, Wanying Sun, Thomas H C Sit, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 6, 2023
Serological assays for differentiating natural COVID-19 infection from vaccine induced immunitySamuel M S Cheng, Jonathan J Lau, Leo C H Tsang, et al.
Nature Medicine|January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccinationSamuel M S Cheng, Chris Ka Pun Mok, Yonna W Y Leung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2022
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated VaccineNancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Pageof 6